Bottom line
What is ETAHX's expense ratio?
ETAHX's expense ratio is 1.54%, or about $154 a year on every $10,000 invested. That is more expensive than 82% of health care sector funds we track (median 0.96%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Oct 28, 2026
ETAHX fee table
| Net expense ratio | 1.54% |
|---|---|
| Gross expense ratio | 1.54% |
| Management fee | 1.1% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.19% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What ETAHX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| ETAHX | $723 | $1,033 | $1,366 | $2,304 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.54% expense ratio costs roughly $81,400 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).
Cheapest way to own Eventide Healthcare & Life Sciences Fund
| Ticker | Class | Expense ratio | Front load |
|---|---|---|---|
| ETIHX | Eventide Healthcare & Life Sciences Fund Class I Shares | 1.29% | 0% |
| ETNHX | Eventide Healthcare & Life Sciences Fund Class N Shares | 1.49% | 0% |
| ETAHX | Eventide Healthcare & Life Sciences Fund Class A Shares | 1.54% | 5.75% |
| ETCHX | Eventide Healthcare & Life Sciences Fund Class C Shares | 2.29% | 0% |